Can a breastfeeding mother safely take Tramacet (tramadol + acetaminophen), and what precautions should be observed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tramacet and Breastfeeding

Tramacet (tramadol + acetaminophen) can be used with extreme caution during breastfeeding, but should be restricted to inpatient settings with close infant monitoring and limited to the lowest effective dose for the shortest duration (ideally 2-3 days maximum). 1

Critical Safety Concerns

The tramadol component poses significant risks to breastfed infants:

  • Tramadol and its active metabolite O-desmethyltramadol are excreted into breast milk 1
  • Case reports document respiratory depression and death in breastfed infants exposed to tramadol 1
  • The FDA issued a warning in April 2017 against tramadol use while breastfeeding 1

Despite the FDA warning, UK Drug Information and Lactation Advisory Service (UKDILAS) reviewed this and concluded tramadol can continue to be used with significant caution, but this represents a nuanced risk-benefit decision 1.

Specific Recommendations

If Tramacet Must Be Used:

Restrict use to inpatient settings only where both mother and infant can be monitored 1. This is the most critical safeguard.

Limit total dose and duration - treatment should not exceed 2-3 days in unsupervised outpatient settings 2, 3.

Monitor the infant intensively for:

  • Increased sleepiness
  • Signs of respiratory depression
  • Sedation and decreased alertness
  • Difficulty feeding 1

Monitor the mother for excessive opioid effects, as maternal toxicity may predict infant risk 1.

Acetaminophen Component

The acetaminophen component is generally considered safe during breastfeeding 3, 4, though recent data shows unexpectedly high mammary transfer with a milk-to-plasma ratio of 1.048 5. However, acetaminophen remains a preferred analgesic during lactation 3.

Safer Alternatives to Consider

Preferred options for breastfeeding mothers include:

  • Ibuprofen or other NSAIDs - better safety profile than tramadol 3, 4
  • Acetaminophen alone - considered safe for breastfeeding 3, 4
  • Morphine - if strong opioid analgesia is required, morphine is preferred over tramadol for short-term use 1, 2
  • Dihydrocodeine - may be preferred over tramadol due to cleaner metabolism 1

Critical Pitfalls to Avoid

Do not prescribe for outpatient use without close monitoring infrastructure - the risk of infant respiratory depression and death is real and unpredictable 1.

Do not exceed 4,000 mg acetaminophen daily from all sources 6.

Do not combine with other tramadol or acetaminophen-containing products, including over-the-counter preparations 6.

Avoid in mothers taking serotonergic agents (SSRIs, SNRIs, triptans) due to seizure and serotonin syndrome risk 6.

FDA Drug Label Guidance

The official Tramacet label states: "Tramadol HCl 37.5 mg/Acetaminophen 325 mg is not recommended for obstetrical preoperative medication or for post-delivery analgesia in nursing mothers because its safety in infants and newborns has not been studied." 6

Following a single IV 100 mg tramadol dose, only 0.1% of the maternal dose was excreted in breast milk within 16 hours 6, but this does not account for the active metabolite accumulation or individual metabolic variations that create unpredictable risk.

Bottom Line

The safest approach is to avoid Tramacet in breastfeeding mothers and use alternative analgesics. If absolutely necessary due to inadequate pain control with safer options, use only in supervised inpatient settings with intensive infant monitoring, limit to 2-3 days maximum, and use the lowest effective dose. The combination of documented infant deaths, FDA warnings, and availability of safer alternatives makes routine outpatient use inappropriate 1, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.